Article: Antares Pharma Acquires Intellectual Property for Prefilled Needle-Free Injection Technology.

Agreement for Needle-Free Injection Technology Reflects

Antares Pharma's Progress on Strategic Plan

MINNEAPOLIS, and BASEL, Switzerland, Nov. 1 /PRNewswire/ --

Antares Pharma, Inc. (Nasdaq: ANTR) today announced the acquisition of specified intellectual property in the area of needle-free drug delivery from Endoscoptic, s.a.r.l., a private company headquartered in Laons, France. As part of the agreement, Antares Pharma has acquired intellectual property including multiple patents for prefilled cartridge technology particularly suited to jet injection. This includes reusable injector system technology adapted for use with prefilled cartridges ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!